A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer
Metin Çetįn(Medical University of South Carolina), Özgür Şahin(Medical University of South Carolina)
Cited by 24
Related Papers
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
|Oncogene|2012|286
The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer
|Oncotarget|2016|59
Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
|Breast Cancer Research and Treatment|2022|58